Diabetic late complications: Will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?
- 1 April 1995
- journal article
- review article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 9 (2) , 104-129
- https://doi.org/10.1016/1056-8727(94)00025-j
Abstract
No abstract availableKeywords
This publication has 233 references indexed in Scilit:
- Deglycation of glycated proteins with hydrazine analoguesLife Sciences, 1993
- Presence of 3-Deoxyglucosone, a Potent Protein Crosslinking Intermediate of Maillard Reaction, in Diabetic SerumBiochemical and Biophysical Research Communications, 1993
- Expression of Receptors for Advanced Glycosylation End Products on Renal Cell Carcinoma Cells in VitroBiochemical and Biophysical Research Communications, 1993
- The epidemiology of diabetic nephropathyDiabetes/Metabolism Research and Reviews, 1989
- Cross-linking and fluorescence changes of collagen by glycation and oxidationBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989
- Production and characterization of antibodies to advanced glycation products on proteinsBiochemical and Biophysical Research Communications, 1989
- Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestatJournal of Diabetic Complications, 1988
- Transcapillary escape rate and relative metabolic clearance of glycated and non-glycated albumin in Type 1 (insulin-dependent) diabetes mellitusDiabetologia, 1987
- Prognosis of diabetics with diabetes onset before the age of thirtyoneDiabetologia, 1978
- Increase in food consumption and growth after treatment with aminoguanidineCellular and Molecular Life Sciences, 1975